Notice of AGM and 2022 Report and Accounts

Intelligent Ultrasound Group PLC
26 May 2023
 

Intelligent Ultrasound Group plc

(the "Group" or the "Company")

 

Notice of Annual General Meeting and 2022 Report and Accounts

Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic' ultrasound company, specialising in artificial intelligence (AI) software and simulation, announces that the following documents have been posted or otherwise been made available to shareholders:

·      2022 Report and Accounts; and

·      Notice of 2023 Annual General Meeting ("AGM")

The Notice of AGM is also available to view on the Company's website at: www.intelligentultrasound.com/reports-presentations.

The AGM will be held at 11.00 a.m. on Wednesday, 21 June 2023 at the Raglan Conference Room, The Celtic Manor, Coldra Wood, Chepstow Road, Newport, NP18 1HQ.

 

Details of how to participate in, and the resolutions that will be tabled for shareholder approval at, the Meeting are set out in the Notice of AGM.

 

For further information, please contact:

 

Intelligent Ultrasound Group plc 

www. intelligentultrasound.com

Stuart Gall, CEO 

Tel: +44 (0)29 2075 6534 

Helen Jones, CFO




 


Cenkos Securities - Nominated Advisor and Broker

Tel:  +44 (0)20 7397 8900 

Giles Balleny / Max Gould (Corporate Finance)


Michael Johnson / Julian Morse (Sales) 




 


Walbrook PR 

Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com 

Anna Dunphy

Mob: +44 (0)7876 741 001 







 

 

ABOUT INTELLIGENT ULTRASOUND GROUP

 

Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to clinic' ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market ('classroom') and artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market ('clinic'). Based in Cardiff in the UK and Atlanta in the US, the Group has two revenue streams:

 

Simulation

 

Real-time hi-fidelity ultrasound education and training through simulation.  Our main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid-19 module and the new BabyWorks Neonate and Paediatric training simulator. To date over 1,450 simulators have been sold to over 700 medical institutions around the world.

 

Clinical AI software

 

Deep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE Healthcare's SonoLyst software that is incorporated in their Voluson Expert 22 and SWIFT ultrasound machines; ScanNav Anatomy PNB that simplifies ultrasound image interpretation by providing the user with real-time AI-based anatomy highlighting for a range of ultrasound guided regional anesthesia procedures; and NeedleTrainer that teaches real-time ultrasound-guided needling and incorporates ScanNav Anatomy PNB. 

 

www.intelligentultrasound.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings